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osting by EAbstract The currently available data identiﬁed IDDM1 and IDDM2 as 2 susceptibility loci for
type 1 diabetes (T1D). The major histocompatibility complex (MHC)/HLA region referred to as
IDDM1 contains several 100 genes known to have a great inﬂuence on T1D risk. Within IDDM2,
a minisatellite variable number of tandem repeats (VNTR) locus in the insulin gene (INS) promoter
region is likely to represent the etiologic polymorphism. The aim of the present work was to study
the association between genotypes and susceptibility to T1D among Egyptian diabetic children and
their family members.
Twenty-ﬁve nuclear Egyptian families with 27 children having T1D, aged 3–14 years, their non-
diabetic 44 sibs, aged 3–15 years and their parents were included in our study. All studied children
were subjected to: detailed history and family pedigree. Thorough clinical examination and anthro-
pometric measurements. Laboratory work up of diabetes including random blood sugar (RBS) andnt of Pediatrics, Faculty of
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40 Soheir S. Abou El-Ella et al.HbA1C. Molecular genetics of INS was studied in four steps; nucleic acid puriﬁcation, ampliﬁca-
tion, sequencing and haplotyping using ﬂanking single nucleotide polymorphisms (SNPs) as surro-
gate markers for minisatellite alleles identiﬁcation.
Analysis of variant repeat distribution among Egyptian families combined with ﬂanking haplo-
types revealed that all our diabetic children had class I alleles of INS; 9 had class IC+, 9 had class
ID+ and 9 had class ID, while all non-diabetic family members had class III alleles of INS.
Therefore the three class I alleles were considered to be equally predisposing to T1D, while class
III alleles are dominantly protective. There was signiﬁcant positive correlations between body mass
index (BMI) and both HbA1C and AST liver enzyme among diabetic children with class IC+ but
not other alleles; indicating that they need close monitoring of their diabetic control and liver func-
tions beside following speciﬁc dietary regimens.
It can be concluded that all class I alleles (IC+, ID+ and ID) are equally important suscepti-
bility factors for T1D among Egyptian children, while class III alleles (IIIA and IIIB) are domi-
nantly protective. It is concluded also that our diabetic children with class IC+ are an especially
endangered subgroup of diabetics. Genotyping for INS-VNTR alleles is recommended for diabetic
children as an important step of diagnostic and follow up regimens and for their non-diabetic family
members for family counseling and early identiﬁcation of potential diabetics. Further studies of
INS-VNTR alleles and HLA haplotypes all over Egypt are recommended to deﬁne the Egyptian
susceptibility loci for T1D and their relations to the clinical and laboratory ﬁndings as an important
national programs.
 2011 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
It is believed that most cases of type 1 diabetes (T1D) result
from a T-cell dependent selective destruction of the insulin –
producing pancreatic B-cells and subsequent irreversible insu-
lin deﬁciency. T1D is caused by predisposing genetic factors in
the presence of permissive environment [1]. At present, more
than 20 regions of the genome are responsible for genetic sus-
ceptibility to T1D. The HLA region of chromosome 6 contains
several 100 genes. Those most strongly associated with the dis-
ease are the HLA class II genes (i.e., HLA-DR, DQ, DP), also
referred to as IDDM1. They contribute approximately 40–
50% of the heritable risk for T1D [3]. Other genes in the cen-
tral, class I [2] and extended class I regions may also increase
T1D risk independent of HLA class II genes [4]. In addition
to IDDM1, the insulin gene (INS), located on chromosome
11 p 15.5 designated as IDDM2 [5] and the CTLA-4 gene
located on chromosome 2q31-35, are now known to inﬂuence
T1D risk [6].
Within IDDM2, a minisatellite non transcribed variable
number of tandem repeat (VNTR) locus in INS promoter re-
gion is likely to represent the etiologic polymorphism [7,8].
Differences in length occur in three discrete classes of VNTR
alleles. THE shorter class of alleles (class I), predisposes to
T1D, whereas the longer class of alleles named class III ap-
pears to be dominantly protective [9,10]. VNTR may bind
transcriptional regulatory proteins related to the expression
of insulin mRNA in the thymus depending on the sequence
of the particular VNTR allele [11]. Class III variants appear
to generate levels of insulin mRNA than class I variants. Such
differences could contribute to a better immune tolerance for
class III positive individuals by increasing the likelihood of
negative selection for auto reactive T-cell clones [12]. Studies
identiﬁed the variable number of tandem repeats as the T1D
susceptibility locus (IDDM2), and classiﬁed alleles either by
size or by ﬂanking haplotypes [13–15]. The effect of INS ap-
pears to vary by ethnicity, with lesser effects in non-Caucasian
populations [16].The aim is to study different types and subtypes of the al-
leles of INS gene among Egyptian children with T1D and their
diabetic and non-diabetic family members and also the relation
to the clinical course of diabetes.2. Patients and methods
2.1. Patients
Twenty-seven probands with T1D and their family members
were studied. Probands (group 1) aged 3–14 years (11 males
and 16 females) with mean age of 8.86 ± 3.93 years, were se-
lected from our endocrine and genetic outpatient clinics and
those admitted to pediatric department, Minouﬁya university
hospitals. Family pedigrees and detailed history suspected
the diabetic family members of selected probands. Diabetes
in probands and their affected family members was diagnosed
according to WHO criteria after oral glucose tolerance test
(OGTT) [17]. Forty four Sibs of type 1 diabetic patients de-
rived from 25 families, were included (group II) (18 males
and 26 females), their ages ranged from 3 to 15 years with
mean age of 7.41 ± 4.27 years.
Healthy age and sex matched children were taken as a con-
trol group aged 3–14 years, with mean age of 3.91 ± 4.11
(group III), (10 males and 10 females) and 45 parents of dia-
betic children were included in our study (group IV), (21
fathers and 24 mothers), with mean age of 44.14 ± 7.82 years
and 35.25 ± 6.11 years for fathers and mothers, respectively.2.2. Methods
All studied diabetic children (after having written informed
consents from parents) were subjected to the following.
A detailed history with stress on age of onset, type of pre-
sentation, and duration of diabetes beside consanguinity and
family history and pedigree analysis.
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ric measurements. Body mass index (BMI), pubertal assess-
ment and full systemic examination.
Laboratory work up of diabetics including urine analysis,
random blood sugar (RBS), complete blood count (CBC), liver
and kidney function tests and glycosylated hemoglobin
(HbA1C) were done. A ‘‘trios’’ design, selecting families for
whom DNA was available from both parents and one or more
offspring, was applied to clarify the imprinting effects [18].
Molecular genetics of insulin gene studied in our molecular
genetics unit, pediatric department, Menouﬁya university hos-
pitals for a total of 136 members, of these 25 nuclear families
(27 probands, 44 siblings, 45 parents and 20 control children).
First step was nucleic acid puriﬁcation by genomic DNA
extraction from peripheral blood using Bio-spin whole blood
genomic DNA extraction kit ‘‘Bioﬂux’’. DNA was liberated,
bounded to the Biospin membrane and then eluted after sev-
eral washings.
Second step was ampliﬁcation. In all PCR reactions 0.5 lg
of genomic DNA was used. PCR primers used are: Sense pri-
mer: 50-ACAGGCTGGACCTCCAG GTGCCTGTTCTG-30.
Antisense primer: 50-TCGTCAGCACCTCTTCCTCAG-
GACCAGC-30. PCR was performed for 35 cycles (45 s at
95 C, 45 s at 70 C and ﬁnal 5 min at 72 C) in samples that
suggested the presence of a class III VNTR allele; the Pst1
genotype was ascertained to conﬁrm this, the PCR was per-
formed for 35 cycles (45 s at 95 C, 45 s at 68 C, 1 min at
72 C and ﬁnal 5 min at 72 C) and the primers used are: Sense
primer: 50-CTCTACCAGCTGGAGAACTA-30. Antisense
primer: 50-GGCTGGTTCAAGGGCTTTAT-30. The PCR
and PCR digest products (for 12 h at 37 C with 10–30 units
of Pst1) were electrophoresed in 2% agarose gels after ethi-
dium bromide staining.
The third step was sequencing; based on the almost com-
plete linkage disequilibrium between INS–VNTR allele classes
and the – 23 Hph1 single nucleotide polymorphism (SNP) in
Caucasian, so the INS–VNTR genotype status by genotyping
the – 23 Hph1 SNP as a surrogate for the VNTR [19]. The A to
T polymorphism that disrupts the Hph1 site CCACT at nucle-
otide 2401 of INS was sequenced in all 136 family members of
parent-child trios. The PCR primers were used to amplify a
574 – bp fragment from genomic DNA. Sequencing was done
using the Big Dye Terminator on an automated DNA capillary
sequencer (Model 3700; Applied Biosystems).
Detection of classes: much of the variations in VNTR length
(repeat unit number of the oligonucleotide sequence: ACA-
GGGGT(G-C)(T-C)GGGG) [20,21] and composition (repeat
element sequence) were captured by dichotomizing VNTR al-
leles into two classes: the short class I alleles (26–63 repeats,
average 570 bp) and longer class III alleles (141–209 repeats,
average 2200 bp). The last step was haplotyping: the identity
of the – 23Hph1 ﬂanking site was determined by allele-speciﬁc
PCR across the minisatellite using universal primer INS-1296
and allele speciﬁc primers INS-23+ and INS-23. Polymor-
phisms at sites 2733 A/C, 2221 Msp1, +805Dra III,
+1127 Pst1 and HUMTH01 was analyzed. Primers 3580-A
and 3580-B were used to amplify a 188 bp region to type the
+3580 Msp1+, polymorphic site. Samples were electropho-
resed for 2 h at 5 V/cm through 4% Metaphor (FMC Bio
products, Rockland, ME) agarose gels in 0.5 · TBE buffer.
Low haplotype diversity in the insulin gene region and strong
linkage disequilibrium (LD) between VNTR allele structureand haplotypes spanning the insulin gene justiﬁed us to use
ﬂanking single nucleotide polymorphisms (SNPs) as surrogate
markers for minisatellite lineages [21,22]. The – 23Hph1 SNP
(rs689) denoted the class I/III subdivision; absence of the
+3580Msp1 restriction site (rs2000993) distinguished the
ID haplotype from other class I haplotypes (IC+/ID+)
[21–23]. Combining allele structure with the presence (+) or
absence () of +3580MSP1+/ deﬁned three class I sub-
groups: IC+, ID+ and ID.
2.2.2.1. Statistical analysis
SPSS version 17 format was used to perform the descriptive
and analytical statistics. As diabetic patients were 27 (less than
30) all the statistical procedures used the non parametric statis-
tics. For descriptive purposes the median and the min–max
values were used. For comparison of the three subgroups the
Kurskal Wallis test was performed, cross tabulation using
Chi square was also used to test the association between cat
goral variables. Finally the non-parametric correlation (Spear-
man correlation) was used to test the correlation between the
quantitative variables. Alpha error was set to 5%.
3. Results
The results of this study illustrated in Tables 1–6 and Figs. 1–3.
Classes and subclasses of INS allele in patients, sibs and
controls (Table 1). Minisatellite VNTR–CR analysis of INS
gene demonstrated that all our diabetic children had class I al-
leles and all their family members as well as controls had class
III alleles, except three mothers had class I allele.
Demographic data family history of diabetes as well as po-
sitive consanguinity were noticeably high among diabetic chil-
dren 92.3%) and (62.9%), respectively. Age of onset of T1D
ranged between 1 and 12 years (median age was 7 years).
Two cases started in the ﬁrst year of life and 4 cases started
up to 2 years of age. The present work showed also a high per-
centage of the occurrence of diabetic ketoacidosis as the initial
presentation of T1D (54.8%). The duration of T1D among our
diabetics was 1–5 years (median = 2 years). There was delayed
onset of puberty in 6 patients (22.22%). The clinical assess-
ment of our patients showed normal body system examination.
Anthropometric measurements and body mass index were
within normal ranges appropriate for age. There is no signiﬁ-
cant difference between age at onset of diabetes, sex of the pa-
tients, family history, positive consanguinity, duration of type
1 diabetes, birth weight, pubertal development, anthropomet-
ric body measurements and the subclasses of INS gene (Table
2).
Laboratory data (Table 3), hepatic and renal function tests
and counts of WBCs and platelets were quite normal for age
and sex without signiﬁcant differences between diabetics and
control children and also among diabetic children of different
subclasses of INS. Mean levels of Hb were slightly decreased
among all diabetics (median = 10.85 g/dl) (p> 0.05).
On the other hand both RBS and HbA1C (medians
212.5 mg/dl and 9.95%, respectively) were signiﬁcantly in-
creased among our diabetic children reﬂecting their poor dia-
betic control and necessitating better control regimens.
Glucosuria was present in all our diabetics except for 6 pa-
tients, while urinary tract infection was present in 5 out of
the 27 diabetic children (18.51%).
Table 1 Comparison of classes and subclasses of INS gene alleles in patients, sibs and controls.
Genotyping Diabetic group (n= 27) Sibs group (n= 44) Control group (n= 20) X2 p Value
% No % No % No
Class I:
IC 33.3 9 0 0 0 0 26.37 <0.001*
ID+ 33.3 9 0 0 0 0 26.37 <0.001*
ID 33.3 9 0 0 0 0 26.37 <0.001*
Class III 0 0 100 44 100 20 66.16 <0.001*
IIIA 10 2
IIIB 15 3
Five controls were genotyped for subclasses III/A and B.
* p< 0.05 = signiﬁcant.
Table 2 Demographic data of all studied diabetic children in relation to their subclasses.
IC (n= 9) ID+ (n= 9) ID (n= 9) X2 p-Value
X± SD % No X ± SD % No X ± SD % No
Age in year 8.5 ± 3.62 8.0 ± 4.0 10.13 ± 36 1.19 >0.05
Sex: males 33.3 3 37.5 4 37.5 4 0.04 >0.05
Birth order
1st 44.4 4 44.4 4 55.5 5 5.6 >0.05
2nd 2.22 2 11.1 1 22.2 2
3rd 11.1 1 11.1 1 11.1 1
4th 22.2 2 33.3 3 11.1 1
Consanguinity +ve 55.6 5 55.6 5 73.6 6 0.26 >0.05
Perinatal history
 Normal 66.7 6 66.7 6 55.6 5 2.11 >0.05
 Low birth weight 22.2 2 12.5 1 33.3 3
 IDM 11.1 1 22.2 2 11.1 1
Family history +ve 66.7 6 88.8 8 33.3 3 9.81 >0.05
Other sibling aﬀection +ve 0 0 22.2 2 22.2 2 1.22 >0.05
Type of presentation DKA 66.7 6 66.7 6 55.6 5 0.29 >0.05
Age at onset 6.72 ± 2.28 6.0 ± 3.57 7.75 ± 3.79 1.05 >0.05
Duration of illness 2.5 ± 0.87 2.0 ± 1.0 2.38 ± 0.58 2.66 >0.05
DKA= diabetic ketoacidosis.
IDM= infant diabetic mother.
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laboratory ﬁndings of all studied diabetic children; the only
signiﬁcant correlation was the logic positive correlation be-
tween the 2 indices of diabetic control i.e., random blood sugar
and HbA1C (p= 0.007). Correlations among subclass IC+
diabetic children were signiﬁcant, there is positive correlation
between BMI and liver functions (p= 0.05) and HbA1C
(p= 0.042); indicating the adverse effect of obesity on liver
function and diabetic control.
Family history, none of the fathers of diabetic children suf-
fered from diabetes mellitus while 3 mothers (12.5%), suffered
from DM, one of them had T1DM and two mothers had
T2DM. Eleven children (44%) of the diabetic group had posi-
tive family history of T2D, from paternal side and 3 children
(12%) of diabetic group had positive family history of T1D
and 5 children (20%) had positive family history of T2D from
maternal side (Table 4).Table 5 demonstrates classes and subclasses of INS gene
among parents of diabetic children.
Twelve mothers having the genotype of the heterozygous
class I/III allele had diabetic children with genotype class I
subgroups as: 6 mothers (50%) had diabetic children with
genotype of IC subclass, 1 mother (8%) had diabetic child with
subclass ID+ and 5 mothers (42%) carried the heterozygous
class I/III had diabetic child with subclass ID. While 8
fathers, who were heterozygous for INS VNTR alleles, had
diabetic children with class I subgroups as: 2 fathers (25%),
had diabetic children with subclass IC, 3 fathers (37.5%) had
diabetic children with ID+ subclass, and 3 fathers (37.5%)
had diabetic children with ID subclass. Higher percentages
of diabetic children with ID subclass were detected in moth-
ers than in fathers who were heterozygous for INS VNTR al-
lele as shown by percentage value of (42%) in mothers in
comparison to (37.5%) in fathers (Table 6).
Table 3 Comparison between genotyping (class I subclasses), some clinical and laboratory data among diabetic group.
IC (n = 9) ID+ (n = 9) ID (n = 9) F test p Value
Random blood sugar (mg/dl) X ± SD 258.33 ± 87.34 215.63 ± 69.31 230.75 ± 59.95 0.74* <0.05*
Glycosylated hemoglobin (%) X ± SD 10.63 ± 1.48 10.21 ± 2.19 11.24 ± 1.12 0.78* >0.05
Liver function tests
 ALT (mg/dl) X ± SD 16.33 ± 6.58 16.87 ± 4.22 16.37 ± 3.99 0.65 >0.05
 AST (mg/dl) X ± SD 21.89 ± 7.62 18.75 ± 4.43 17.63 ± 1.99 0.63 >0.05
Kidney function tests
 Blood urea nitrogen (mg/dl) X ± SD 16.89 ± 6.55 18.13 ± 1.36 18.38 ± 5.29 0.33* >0.05
 Creatinine (mg/dl) X ± SD 0.82 ± 0.07 0.79 ± 0.12 0.83 ± 0.12 0.78* >0.05
Complete blood picture
 Hb (gm/dl) X ± SD 11.1 ± 0.44 11.4 ± 0.82 11.08 ± 0.41 1.21* >0.05
 WBC’S (·103/mm3) X ± SD 6.63 ± 3.84 7.8 ± 3.52 7.8 ± 3.72 0.55 >0.05
 Platelets (·103/mm3) X ± SD 226.22 ± 16.72 228.37 ± 14.02 230.75 ± 15.82 0.22* >0.05
* p Value < 0.05 = signiﬁcant.
Table 5 Frequency distribution of INS VNTR alleles among parents of diabetic group.
INS genotyping Fathers of diabetic patients (n= 21) Mothers of diabetic patients (n= 24) X2 p-Value
% No % No
INS VNTR
Class I 0 0 12.5 3 2.81 >0.05
Class III
IIIA 61.9 13 7.5 9 2.67 >0.05
IIIB 2 1
1 1
Class I/III
Heterozygosis 38.1 8 50 12 0.64 >0.05
N.B: Subclassiﬁcation of class III into A and B were done only for 5 of the parents.
Table 4 Family history of DM among parents and siblings of diabetic children.
Family number Family history of DM Family pedigre
Siblings Parents
Fathers
(mean age in years 44.14 ± 7.82)
Mothers
(mean age in years 35.25 ± 6.11)
10 ve ve T2D
11 +ve ve ve
22 ve ve T2D
24 +ve ve ve
25 ve ve T1D
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Table 6 Relation between class I/III alleles of parents and subclasses of diabetic patients.
Diabetic group Mothers I/III (n= 12) Fathers I/III (n= 8) X2 p-Value
% No % No
IC (9) 50 6 25 2 1.25 >0.05
ID+ (9) 8 1 37.5 3 2.55 >0.05
ID (9) 42 5 37.5 3 0.03 >0.05
Figure 1 Gel electrophoresis of the PCR of the INS gene for
diabetic, sibs and control groups. Lane M: DNA ladder of 100-bp,
starting from 100 to 1200 bp (on the right side). Lanes 1, 2, 3, 8, 9,
10: indicated samples from diabetic children, positive for class I
genotyping as shown by the presence of corresponding bands on
gel along the rum (at 200 bp). Lanes 4–6: indicated samples from
sibs of diabetic children. No bands were visualized on gel. Lane 7:
indicated sample of PCR from a normal child.
Figure 2 Genotypes of different Egyptian diabetic children at
the INS 30 PstI RFLP. In most, the presence of the PstI restriction
site indicates the presence of a class III allele visualized at the
VNTR on the chromosome, whereas the absence of the restriction
site indicates the presence of a class I allele on the chromosome.
The numbering at the top of each lane indicates different samples.
Figure 3 Sequence of various repeat elements present in VNTR
regions.
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To our knowledge, this is the ﬁrst study to be done in Egypt on
diabetic children.
Whole genome linkage scans have shown that the major
histocompatibility complex (MHC)/HLA region on chromo-
some 6p21 contains the major genetic component of the dis-
ease (IDDM1) [24,25]. Another established disease locus,
IDDM2, has been mapped to chromosome 11p15.5 and carries
a relatively more modest but clearly deﬁned genetic effect
[5,26]. The insulin gene variable number tandem repeats locus
(INS-VNTR) is the best candidate for T1D susceptibility lo-
cus; IDDM2 [27]. The INS-VNTR locus affects expression
of the insulin gene and its precursors in the thymus, consistent
with a model in which either positive or negative selection of
auto reactive T-cell clones against epitopes from preproinsulin
(PPI) occurs [28–31]. Overall the biological pathways leading
to T1D are not fully understood and the nature of the interac-
tion of the products of HLA class II and INS-VNTR in the
disease process is still unclear. Indeed, the functional conse-
quences of INS-VNTR variation in T1D susceptibility might
include extra-thymic immunological and metabolic effects
[1,32]. Furthermore, the joint action of INS gene and HLA
variation might also be inﬂuenced by additional genetic and
environmental factors, which could vary in different popula-
tions [1]. The apparent role of INS-VNTR in susceptibility
to T1D may be modiﬁed by neighbouring haplotypes and
therefore IDDM2 could be a multi-locus etiology [21]. The
present work analyzed INS-VNTR distribution within a num-
ber of Egyptian families and combined this with ﬂanking hap-
lotypes to deﬁne different ancestral allele lineages. Previous
studies identiﬁed INS-VNTR as T1D susceptibility locus and
classiﬁed its alleles either by size or by ﬂanking haplotypes into
a shorter class I variant predisposing to T1D and a longer class
III variant which appears to be dominantly protective [9,10].
The effects of INS-VNTR alleles vary by ethnicity [16]. The
present study revealed by analysis of variant repeat distribu-
tion among different Egyptian families combined with ﬂanking
haplotypes that all our diabetic children had class I alleles.
Nine of them had subclass IC; 9 had subclass ID+ and 9
had subclass ID. While all their non-diabetic family members
had class III (IIIA and IIIB). Linkage disequilibrium between
the INS minisatellite and HUMTH01 was analyzed. HUM-
TH01 has 5 common alleles composed of 6 (allele Z – 16) to
10 (allele Z) tandem repeats of a TCAT tetramer. Haplotypes
of the 5 subclasses of the minisatellite were each dominated by
a different allele of HUMTH01 conﬁrming that each subclass
represented a distinct ancestral lineage that has retained link-
age disequilibrium over a region of at least 9 kb. The greatest
breakdown of LD was within the ID lineage, where ID
haplotypes were associated with both allele Z– 16 (59% of
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[33]. In general, class I alleles were found to be equally predis-
posing to T1D with the exception of ID alleles which are pro-
tective at certain circumstances. ID alleles are typically larger
than either IC or ID+ alleles. A size threshold was therefore
alleged, above which class I alleles are protective. Alterna-
tively, protection was supposed to be due to variant repeat dis-
tribution within the insulin minisatellite (ABA motif 10
repeats, 50 CAC block, a central FAC block and a 30 F repeat).
However, ABA repeats are shared in all IC, while other repeats
are shared by most ID+ alleles, suggesting that ID protec-
tion is not mediated by variant repeat composition or distribu-
tion. A strong etiological candidate for ID protection is
therefore the ﬂanking haplotype. All ID alleles lack the
+3580Msp1+/ polymorphic site within the ﬁrst intron of
IGF2 >4 kb downstream of the minisatellite, which is present
in 99.6% of all other haplotypes. It is therefore suggested that
IDDM2 may have a multi-locus etiological basis, with the
putative effects of the secondary polymorphism depending
on both parental genotype and gender [7,22]. The 3 subclasses
(IC, ID+ and ID) were equally presented among children
with type 1 diabetes. Failure to discriminate predisposing
and protective effects of the three subclasses could be due to
the small sample size or to racial genotypic differences. The
complete association in 100% of our children with T1D with
class I alleles in contrast to occurrence of class III alleles in
T1D in 2.5% of diabetic children in a German study [34]
and 24% of a Czech population [35]. It is to be stated that
our research attributed a deﬁnite predictive role in T1D for
genotyping of the insulin gene region polymorphism with class
I alleles in all our children with T1D in contrast to Undlien et
al. [16] who found that it is not a deﬁnite tool in the prediction
of T1D. On the other hand, Cinek et al. [35] stated that the
insulin gene genotyping confers important information on
T1D risk in Czech population and they recommended using
it in determining the disease risk along with the HLA – DQ
typing. The absence of classes IIIA (protective haplotype)
and IIIB (very protective haplotype) among diabetics and
being the only haplotypes detected among our non-diabetic
family members conﬁrms the protective role of these haplo-
types among Egyptian families. Differences in repeat-type dis-
tribution and composition may account for this [7]. H-type
repeat may protect against disease by increasing insulin gene
transcription through the binding of the pur – 1 transcription
factor [36], although its presence in IIIA (protective haplotype)
but not IIIB (very protective haplotype) alleles excludes it as
the sole determinant of protection. A-type repeats elevate insu-
lin gene transcription. However; the higher frequency and copy
number of A-type repeats found in IIIA alleles compared to
the IIIB alleles is against this functional role. However, in IIIB
alleles 5/6 repeats closet to the insulin gene were A-type com-
pared to 0/6 in IIIA alleles, so repeat distribution may be a
more important factor than absolute composition [7]. F-type
repeats within each lineage were conferred a protective role
[22]; however, the present study found no correlation between
the number of F-type repeats and the level of protection; for
example there was no detectable difference between the effects
associated with IC (2F-repeats) and ID+ (4F repeats) alleles.
As regards demographic, clinical and laboratory ﬁndings
among our children with T1D and their relations to INS sub-
classes. The present work found a markedly high familial
occurrence of T1D (64%) irrespective of INS subclasses whichmay be attributed to our rural cultural habit of marriage of rel-
ative (documented by high +ve consanguinity in 56%), It was
also observed that two families had other siblings affected with
T1D (Families No. 11, 24) beside the genetic basis of T1D as a
disease and also the racial differences. A study from Saudi
Arabia [37], found +ve ﬁrst degree family history for T1D
in 28% of patients. A possible explanation can be deduced
from Snehaltha et al. [38] who stated that there is evidence that
genetic and ethnic variations are present in the familial occur-
rence of T1D. There was also a high occurrence rate of diabetic
ketoacidosis as the initial presentation of T1D among our dia-
betics (68%) regardless of their subclass of INS nearly similar
(25%) to Munk [39]. The present work showed no association
between age at onset of T1D as insulin gene variation in agree-
ment with Desai et al [21]. On the other hand there was contra-
diction between the present study and previous studies as
regards the insigniﬁcant differences of the birth weight [40–
44] of our diabetics and also their delayed pubertal onset
[45]. These contradictions may be explained by the smaller
sample size of our study and/or racial differences. The present
work showed that BMI is more sensitive than all anthropomet-
ric measurements to be affected earlier in T1D and that hemo-
globin level is the most vulnerable hematological parameter to
be altered in T1D. Likewise, urinary tract infection was found
in a considerable number of our children with T1D. Correla-
tion studies done among our diabetic children put subclass
IC as the subclass with a considerable risk of obesity (high
BMI), poor diabetic control and impairment of liver function.
The current study showed that fathers, free from either
T1D and T2D, showed that 13 of them (61.9%) were positive
for INS class III allele. Eight fathers (38.1%), were positive for
the heterozygous class I/III. As regards mothers of diabetic pa-
tients, 3 diabetic mothers (12.5%), were positive for the predis-
posing class I allele. Nine mothers (37.5%) were genotyped
under class III allele, and 12 mothers (50%) were positive
for the heterozygous class I/III.
As regards parent-offspring relationship, 5 diabetic patients
(42%) genotyped for ID subclass, were born to heterozygous
I/III mothers and 3 diabetic patients (37.5%), who were geno-
typed for ID sub class, were born to heterozygous I/III
fathers. Although this may be contrasted with the previously
mentioned that Class ID allele carries protection when trans-
mitted from heterozygous fathers. Dos Santos et al stated a
restriction of ID protection to transmission from fathers
[46,47].
This does raise the possibility that ID alleles may be more
protective against T1DM than class III alleles transmitted
from ID/III heterozygous fathers.
To clarify that protective effect of the ID lineage was a
property speciﬁcally of allele 814, Le Stunff et al. [47] stated
that molecular genetic studies divided all ID alleles into those
of 42 repeats and those of other sizes and analyzed the risk of
transmission into offsprings.
Dos Santos et al. [46] reported that levels of protection
associated with ID alleles were indistinguishable between
ID/III A and ID/IIIB fathers, indicating that the ID ef-
fect is not signiﬁcantly modulated by differences between the
lineages of untransmitted class III alleles.
Meigs et al. [48] identiﬁed that this potential evidence of
imprinting effect about the paternally transmitted alleles al-
tered with presence of maternal hyperglycemia, that is, espe-
cially if the mother had type 1 DM. However, this parent of
46 Soheir S. Abou El-Ella et al.origin effect has not been replicated in an independent family
data set and until this is achieved its existence and properties
remains speculative.
In fact our results supported that the molecular structure of
the INS VNTR allele, not only its overall length is associated
with variations of insulin secretion. It may be important to test
the ramiﬁcations of this observation for class I association
with type 1diabetes susceptibility [49].
In analogy, to the genes for sickle cell anemia, Tay-sachs
disease and thalassemia, which are examples of population-
speciﬁc genetic markers for susceptibility, INS class I, result
in higher incidence of T1D, and marks T1D susceptibility,
mediated by both composition and variant repeat distribution.
It is important to note that it is the contrasting frequencies of
susceptibility alleles at different susceptibility loci in the paren-
tal populations that determine the rising disease incidence in
the offspring [50].
It is concluded that: (1) Class I alleles of INS are important
susceptibility factors for T1D among Egyptian children (chil-
dren with class I alleles are at a greater risk to develop the dis-
ease). (2) Our diabetic children having subclass IC are more
vulnerable than those with ID+ and ID alleles and need
strict diabetic control and follow up. (3) Class III alleles are
dominantly protective against T1D among Egyptians.
It is recommended to include genotyping for INS-VNTR
alleles as an important step of the family counseling of T1D
and as an essential part of diagnostic and prognostic work
up of diabetic children. It is also recommended to periodically
check and early manage obesity, anemia, poor diabetic con-
trol, liver function affection and urinary tract infection among
all our diabetic children especially the more vulnerable diabetic
children with class IC alleles. It is to be recommended to deter-
mine INS-VNTR alleles beside the HLA haplotypes among
diabetic children and their relatives all over Egypt in relation
to clinical ﬁndings as an important national project.
The authors declare that there is no conﬂict of interest.
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